Insulin signaling in the central nervous system: Learning to survive

Progress in Neurobiology

Volumn 79, Issue 4, 2006, Pages 205-221

  van der Heide, Lars P ^a   Ramakers, Geert M J ^a   Smidt, Marten P ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Alzheimer's disease; Brain; Cognition; Development; NMDA; PI3K; PKB Akt; Synaptic plasticity

Indexed keywords

ALPHA TUBULIN; AMYLOID BETA PROTEIN; BETA TUBULIN; CASPASE 9; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCOSE; GLYCOGEN SYNTHASE KINASE; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN KINASE FYN; PROTEIN TYROSINE PHOSPHATASE SHP 2; RAF PROTEIN; SOMATOMEDIN; SOMATOMEDIN C RECEPTOR; TAU PROTEIN; UNINDEXED DRUG;

ALZHEIMER DISEASE; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; ENZYME STRUCTURE; HUMAN; IMMUNOCYTOCHEMISTRY; LEARNING; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MEMORY; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC POTENTIAL; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INSULIN; NEURODEGENERATIVE DISEASES; NEURONAL PLASTICITY; NEURONS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 33748295795     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2006.06.003     Document Type: Review

References (173)

1. Abbott M.A., Wells D.G., and Fallon J.R. The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses. J. Neurosci. 19 (1999) 7300-7308
2. Adachi M., Katsumura K.R., Fujii K., Kobayashi S., Aoki H., and Matsuzaki M. Proteasome-dependent decrease in Akt by growth factors in vascular smooth muscle cells. FEBS Lett. 554 (2003) 77-80
3. Ahmadian G., Ju W., Liu L., Wyszynski M., Lee S.H., Dunah A.W., Taghibiglou C., Wang Y., Lu J., Wong T.P., Sheng M., and Wang Y.T. Tyrosine phosphorylation of GluR2 is required for insulin-stimulated AMPA receptor endocytosis and LTD. EMBO J. 23 (2004) 1040-1050
4. Alessi D.R. Discovery of PDK1, one of the missing links in insulin signal transduction. Colworth Medal Lecture. Biochem. Soc. Trans. 29 (2001) 1-14
5. Artola A., Brocher S., and Singer W. Different voltage-dependent thresholds for inducing long-term depression and long-term potentiation in slices of rat visual cortex. Nature 347 (1990) 69-72
6. Authier F., Posner B.I., and Bergeron J.J. Insulin-degrading enzyme. Clin. Invest. Med. 19 (1996) 149-160
7. Banks W.A. The source of cerebral insulin. Eur. J. Pharmacol. 490 (2004) 5-12
8. Baskin D.G., Figlewicz D.P., Woods S.C., Porte Jr. D., and Dorsa D.M. Insulin in the brain. Annu. Rev. Physiol. 49 (1987) 335-347
9. Baskin D.G., Porte Jr. D., Guest K., and Dorsa D.M. Regional concentrations of insulin in the rat brain. Endocrinology 112 (1983) 898-903
10. Baskin D.G., Woods S.C., West D.B., van Houten M., Posner B.I., Dorsa D.M., and Porte Jr. D. Immunocytochemical detection of insulin in rat hypothalamus and its possible uptake from cerebrospinal fluid. Endocrinology 113 (1983) 1818-1825
11. Begum N., and Ragolia L. High glucose and insulin inhibit VSMC MKP-1 expression by blocking iNOS via p38 MAPK activation. Am. J. Physiol. Cell Physiol. 278 (2000) C81-C91
12. Bennett R.G., Duckworth W.C., and Hamel F.G. Degradation of amylin by insulin-degrading enzyme. J. Biol. Chem. 275 (2000) 36621-36625
13. Bertram L., Blacker D., Mullin K., Keeney D., Jones J., Basu S., Yhu S., Mclnnis M.G., Go R.C., Vekrellis K., Selkoe D.J., Saunders A.J., and Tanzi R.E. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 290 (2000) 2302-2303
14. Biessels G.J., Staekenborg S., Brunner E., Brayne C., and Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 5 (2006) 64-74
15. Biessels G.J., van der Heide L.P., Kamal A., Bleys R.L., and Gispen W.H. Ageing and diabetes: implications for brain function. Eur. J. Pharmacol. 441 (2002) 1-14
16. Born J., Lange T., Kern W., McGregor G.P., Bickel U., and Fehm H.L. Sniffing neuropeptides: a transnasal approach to the human brain. Nat. Neurosci. 5 (2002) 514-516
17. Brunet A., Datta S.R., and Greenberg M.E. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr. Opin. Neurobiol. 11 (2001) 297-305
18. Cellini E., Bagnoli S., Tedde A., Nacmias B., Piacentini S., and Sorbi S. Insulin degrading enzyme and alpha-3 catenin polymorphisms in Italian patients with Alzheimer disease. Alzheimer Dis. Assoc. Disord. 19 (2005) 246-247
19. Chen X., Garelick M.G., Wang H., Lil V., Athos J., and Storm D.R. PI3 kinase signaling is required for retrieval and extinction of contextual memory. Nat. Neurosci. 8 (2005) 925-931
20. Clarke D.W., Boyd Jr. F.T., Kappy M.S., and Raizada M.K. Insulin binds to specific receptors and stimulates 2-deoxy-d-glucose uptake in cultured glial cells from rat brain. J. Biol. Chem. 259 (1984) 11672-11675
21. Craft S., Asthana S., Cook D.G., Baker L.D., Cherrier M., Purganan K., Wait C., Petrova A., Latendresse S., Watson G.S., Newcomer J.W., Schellenberg G.D., and Krohn A.J. Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype. Psychoneuroendocrinology 28 (2003) 809-822
22. Craft S., Asthana S., Newcomer J.W., Wilkinson C.W., Matos I.T., Baker L.D., Cherrier M., Lofgreen C., Latendresse S., Petrova A., Plymate S., Raskind M., Grimwood K., and Veith R.C. Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. Arch. Gen. Psychiatry 56 (1999) 1135-1140
23. Craft S., Newcomer J., Kanne S., Dagogo-Jack S., Cryer P., Sheline Y., Luby J., Dagogo-Jack A., and Alderson A. Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiol. Aging 17 (1996) 123-130
24. Craft S., Peskind E., Schwartz M.W., Schellenberg G.D., Raskind M., and Porte Jr. D. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology 50 (1998) 164-168
25. Craft S., and Watson G.S. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol. 3 (2004) 169-178
26. Datta S.R., Brunet A., and Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 13 (1999) 2905-2927
27. Deltour L., Leduque P., Blume N., Madsen O., Dubois P., Jami J., and Bucchini D. Differential expression of the two nonallelic proinsulin genes in the developing mouse embryo. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 527-531
28. Deltour L., Montagutelli X., Guenet J.L., Jami J., and Paldi A. Tissue- and developmental stage-specific imprinting of the mouse proinsulin gene, Ins2. Dev. Biol. 168 (1995) 686-688
29. de Pablo F., Girbau M., Gomez J.A., Hernandez E., and Roth J. Insulin antibodies retard and insulin accelerates growth and differentiation in early embryos. Diabetes 34 (1985) 1063-1067
30. Devaskar S.U., Giddings S.J., Rajakumar P.A., Carnaghi L.R., Menon R.K., and Zahm D.S. Insulin gene expression and insulin synthesis in mammalian neuronal cells. J. Biol. Chem. 269 (1994) 8445-8454
31. Dickson B.J. Development. Wiring the brain with insulin. Science 300 (2003) 440-441
32. Doornbos R.P., Theelen M., van der Hoeven P.C., van Blitterswijk W.J., Verkleij A.J., and van Bergen en Henegouwen P.M. Protein kinase Czeta is a negative regulator of protein kinase B activity. J. Biol. Chem. 21A (1999) 8589-8596
33. Dudek S.M., and Bear M.F. Homosynaptic long-term depression in area CA1 of hippocampus and effects of N-methyl-d-aspartate receptor blockade. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 4363-4367
34. Dudek S.M., and Bear M.F. Bidirectional long-term modification of synaptic effectiveness in the adult and immature hippocampus. J. Neurosci. 13 (1993) 2910-2918
35. Dunwiddie T., and Lynch G. Long-term potentiation and depression of synaptic responses in the rat hippocampus: localization and frequency dependency. J. Physiol. 276 (1978) 353-367
36. Dunwiddie T., Madison D., and Lynch G. Synaptic transmission is required for initiation of long-term potentiation. Brain Res. 150 (1978) 413-417
37. Farris W., Mansourian S., Leissring M.A., Eckman E.A., Bertram L., Eckman C.B., Tanzi R.E., and Selkoe D.J. Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. Am. J. Pathol. 164 (2004) 1425-1434
38. Frolich L., Blum-Degen D., Bernstein H.G., Engelsberger S., Humrich J., Laufer S., Muschner D., Thalheimer A., Turk A., Hoyer S., Zochling R., Boissl K.W., Jellinger K., and Riederer P. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J. Neural Transm. 105 (1998) 423-438
39. Fukunaga K., Ishigami T., and Kawano T. Transcriptional regulation of neuronal genes and its effect on neural functions: expression and function of forkhead transcription factors in neurons. J. Pharmacol. Sci. 98 (2005) 205-211
40. Garrity P.A., Rao Y., Salecker I., McGlade J., Pawson T., and Zipursky S.L. Drosophila photoreceptor axon guidance and targeting requires the dreadlocks SH2/SH3 adapter protein. Cell 85 (1996) 639-650
41. Giddings S.J., Chirgwin J.M., and Permutt M.A. Glucose regulated insulin biosynthesis in isolated rat pancreatic islets is accompanied by changes in proinsulin mRNA. Diab. Res. 2 (1985) 71-75
42. Gilley J., Coffer P.J., and Ham J. FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J. Cell. Biol. 162 (2003) 613-622
43. Gispen W.H., and Biessels G.J. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci. 23 (2000) 542-549
44. Goldstein B.J., and Dudley A.L. Heterogeneity of messenger RNA that encodes the rat insulin receptor is limited to the domain of exon 11. Analysis by RNA heteroduplex mapping, amplification of cDNA, and in vitro translation. Diabetes 41 (1992) 1293-1300
45. Groves C.J., Wiltshire S., Smedley D., Owen K.R., Frayling T.M., Walker M., Hitman G.A., Levy J.C., O'Rahilly S., Menzel S., Hattersley A.T., and McCarthy M.I. Association and haplotype analysis of the insulin-degrading enzyme (IDE) gene, a strong positional and biological candidate for type 2 diabetes susceptibility. Diabetes 52 (2003) 1300-1305
46. Haddad J.J. N-Methyl-d-aspartate (NMDA) and the regulation of mitogen-activated protein kinase (MAPK) signaling pathways: a revolving neurochemical axis for therapeutic intervention?. Prog. Neurobiol. 11 (2005) 252-282
47. Hanada M., Feng J., and Hemmings B.A. Structure, regulation and function of PKB/AKT-a major therapeutic target. Biochim. Biophys. Acta Proteins Proteom. 1697 (2004) 3-16
48. Hardy J. The genetic causes of neurodegenerative diseases. J. Alzheimers Dis. 3 (2001) 109-116
49. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
50. Havrankova J., Brownstein M., and Roth J. Insulin and insulin-receptors in rodent brain. Diabetologia 20 (1981) 268-273
51. Havrankova J., and Roth J. Insulin receptors are widely distributed in central nervous-system of rat. Nature 212 (1978) 827-829
52. Havrankova J., Roth J., and Brownstein M.J. Insulin receptors in brain. Adv. Metab. Disord. 10 (1983) 259-268
53. Havrankova J., Schmechel D., Roth J., and Brownstein M. Identification of insulin in rat-brain. Proc. Natl. Acad. Sci. U.S.A. 75 (1978) 5737-5741
54. Heidenreich K.A., Zahniser N.R., Berhanu P., Brandenburg D., and Olefsky J.M. Structural differences between insulin receptors in the brain and peripheral target tissues. J. Biol. Chem. 258 (1983) 8527-8530
55. Hernandez-Sanchez C., Mansilla A., de la Rosa E.J., Pollerberg G.E., Martinez-Salas E., and de Pablo F. Upstream AUGs in embryonic proinsulin mRNA control its low translation level. EMBO J. 22 (2003) 5582-5592
56. Hernandez-Sanchez C., Rubio E., Serna J., de la Rosa E.J., and de Pablo F. Unprocessed proinsulin promotes cell survival during neurulation in the chick embryo. Diabetes 51 (2002) 770-777
57. Hoekman M.F., Jacobs F.M., Smidt M.P., and Burbach J.P. Spatial and temporal expression of FoxO transcription factors in the developing and adult murine brain. Gene Exp. Patterns 6 (2006) 134-140
58. Horsch D., and Kahn C.R. Region-specific mRNA expression of phosphatidylinositol 3-kinase regulatory isoforms in the central nervous system of C57BL/6J mice. J. Comp. Neurol. 415 (1999) 105-120
59. Hosaka T., Biggs III W.H., Tieu D., Boyer A.D., Varki N.M., Cavenee W.K., and Arden K.C. Disruption of forkhead transcription factor (FoxO) family members in mice reveals their functional diversification. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 2975-2980
60. Hou L., and Klann E. Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J. Neurosci. 24 (2004) 6352-6361
61. Hoyer S. Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J. Neural Transm. 105 (1998) 415-422
62. Hrabetova S., and Sacktor T.C. Bidirectional regulation of protein kinase M zeta in the maintenance of long-term potentiation and long-term depression. J. Neurosci. 16 (1996) 5324-5333
63. Hrabetova S., and Sacktor T.C. Transient translocation of conventional protein kinase C isoforms and persistent downregulation of atypical protein kinase Mzeta in long-term depression. Brain Res. Mol. Brain Res. 95 (2001) 146-152
64. Huang C.C., Lee C.C., and Hsu K.S. An investigation into signal transduction mechanisms involved in insulin-induced long-term depression in the CA1 region of the hippocampus. J. Neurochem. 89 (2004) 217-231
65. Ishii D.N. Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy. Brain Res. Brain Res. Rev. 20 (1995) 47-67
66. Jacobs F.M., van der Heide L.P., Wijchers P.J., Burbach J.P., Hoekman M.F., and Smidt M.P. FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics. J. Biol. Chem. 278 (2003) 35959-35967
67. Kalmijn S., Feskens E.J., Launer L.J., Stijnen T., and Kromhout D. Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetologia 38 (1995) 1096-1102
68. Kawano T., Morioka M., Yano S., Hamada J., Ushio Y., Miyamoto E., and Fukunaga K. Decreased Akt activity is associated with activation of forkhead transcription factor after transient forebrain ischemia in gerbil hippocampus. J. Cereb. Blood Flow Metab. 22 (2002) 926-934
69. Kelly A., Maguire C., and Lynch M.A. Deficits in nerve growth factor release and tyrosine receptor kinase phosphorylation are associated with age-related impairment in long-term potentiation in the dentate gyrus. Neuroscience 95 (2000) 359-365
70. Kenyon C., Chang J., Gensch E., Rudner A., and Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature 366 (1993) 461-464
71. Kern W., Born J., Schreiber H., and Fehm H.L. Central nervous system effects of intranasally administered insulin during euglycemia in men. Diabetes 48 (1999) 557-563
72. Kimura K.D., Tissenbaum H.A., Liu Y., and Ruvkun G. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277 (1997) 942-946
73. Kirschner R.J., and Goldberg A.L. A high molecular weight metalloendoprotease from the cytosol of mammalian cells. J. Biol. Chem. 258 (1983) 967-976
74. Kneussel M. Dynamic regulation of GABA(A) receptors at synaptic sites. Brain Res. Brain Res. Rev. 39 (2002) 74-83
75. Lawlor M.A., and Alessi D.R. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?. J. Cell. Sci. 114 (2001) 2903-2910
76. Lee C.C., Huang C.C., Wu M.Y., and Hsu K.S. Insulin stimulates postsynaptic density-95 protein translation via the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway. J. Biol. Chem. 280 (2005) 18543-18550
77. Leibson C.L., Rocca W.A., Hanson V.A., Cha R., Kokmen E., Obrien P.C., and Palumbo P.J. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am. J. Epidemiol. 145 (1997) 301-308
78. Leissring M.A., Farris W., Chang A.Y., Walsh D.M., Wu X., Sun X., Frosch M.P., and Selkoe D.J. Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40 (2003) 1087-1093
79. Liao G.Y., and Leonard J.P. Insulin modulation of cloned mouse NMDA receptor currents in Xenopus oocytes. J. Neurochem. 73 (1999) 1510-1519
80. Lin C.H., Yeh S.H., Lin C.H., Lu K.T., Leu T.H., Chang W.C., and Gean P.W. A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron 31 (2001) 841-851
81. Liu L., Brown III J.C., Webster W.W., Morrisett R.A., and Monaghan D.T. Insulin potentiates N-methyl-d-aspartate receptor activity in Xenopus oocytes and rat hippocampus. Neurosci. Lett. 192 (1995) 5-8
82. Liu Y.F., Paz K., Herschkovitz A., Alt A., Tennenbaum T., Sampson S.R., Ohba M., Kuroki T., LeRoith D., and Zick Y. Insulin stimulates PKCzeta-mediated phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated mechanism to negatively regulate the function of IRS proteins. J. Biol. Chem. 276 (2001) 14459-14465
83. Luchsinger J.A., Tang M.X., Shea S., and Mayeux R. Hyperinsulinemia and risk of Alzheimer disease. Neurology 63 (2004) 1187-1192
84. Lupien S.B., Bluhm E.J., and Ishii D.N. Systemic insulin-like growth factor-I administration prevents cognitive impairment in diabetic rats, and brain IGF regulates learning/memory in normal adult rats. J. Neurosci. Res. 74 (2003) 512-523
85. Lupien, S.B., Bluhm, E.J., Ishii, D.N., 2005. Effect of IGF-I on DNA, RNA, and protein loss associated with brain atrophy and impaired learning in diabetic rats. Neurobiol Dis.
86. Malenka R.C. Synaptic plasticity and AMPA receptor trafficking. Ann. NY Acad. Sci. 1003 (2005) 1-11
87. Malenka R.C. The long-term potential of LTP. Nat. Rev. Neurosci. 4 (2003) 923-926
88. Man H.Y., Ju W., Ahmadian G., and Wang Y.T. Intracellular trafficking of AMPA receptors in synaptic plasticity. Cell. Mol. Life Sci. 57 (2000) 1526-1534
89. Man H.Y., Lin J.W., Ju W.H., Ahmadian G., Liu L., Becker L.E., Sheng M., and Wang Y.T. Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization. Neuron 25 (2000) 649-662
90. Man H.Y., Wang Q., Lu W.Y., Ju W., Ahmadian G., Liu L., D'Souza S., Wong T.P., Taghibiglou C., Lu J., Becker L.E., Pei L., Liu F., Wymann M.P., MacDonald J.F., and Wang Y.T. Activation of PI3-kinase is required for AMPA receptor insertion during LTP of mEPSCs in cultured hippocampal neurons. Neuron 38 (2003) 611-624
91. Mansilla A., Lopez-Sanchez C., de la Rosa E.J., Garcia-Martinez V., Martinez-Salas E., de Pablo F., and Hernandez-Sanchez C. Developmental regulation of a proinsulin messenger RNA generated by intron retention. EMBO Rep. 6 (2005) 1182-1187
92. Marini A.M., Jiang X., Wu X., Tian F., Zhu D., Okagaki P., and Lipsky R.H. Role of brain-derived neurotrophic factor and NF-kappaB in neuronal plasticity and survival: from genes to phenotype. Restor. Neurol. Neurosci. 22 (2004) 121-130
93. Maroni P., Bendinelli P., and Piccoletti R. Early intracellular events induced by in vivo leptin treatment in mouse skeletal muscle. Mol. Cell. Endocrinol. 201 (2003) 109-121
94. Matsuzaki H., Tamatani M., Mitsuda N., Namikawa K., Kiyama H., Miyake S., and Tohyama M. Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampal neurons. J. Neurochem. 73 (1999) 2037-2046
95. McDermott J.R., and Gibson A.M. Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme. Neurochem. Res. 22 (1997) 49-56
96. Mill J.F., Chao M.V., and Ishii D.N. Insulin, insulin-like growth factor II, and nerve growth factor effects on tubulin mRNA levels and neurite formation. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 7126-7130
97. Misbin R.I., and Almira E.C. Degradation of insulin and insulin-like growth factors by enzyme purified from human erythrocytes. Comparison of degradation products observed with A14- and B26-[125I]monoiodoinsulin. Diabetes 38 (1989) 152-158
98. Moelling K., Schad K., Bosse M., Zimmermann S., and Schweneker M. Regulation of Raf-Akt Cross-talk. J. Biol. Chem. 277 (2002) 31099-31106
99. Morales A.V., Serna J., Alarcon C., de la Rosa E.J., and de Pablo F. Role of prepancreatic (pro)insulin and the insulin receptor in prevention of embryonic apoptosis. Endocrinology 138 (1997) 3967-3975
100. Ngezahayo A., Schachner M., and Artola A. Synaptic activity modulates the induction of bidirectional synaptic changes in adult mouse hippocampus. J. Neurosci. 20 (2000) 2451-2458
101. Niswender K.D., and Schwartz M.W. Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities. Front. Neuroendocrinol. 24 (2003) 1-10
102. Ogg S., Paradis S., Gottlieb S., Patterson G.I., Lee L., Tissenbaum H.A., and Ruvkun G. The fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389 (1997) 994-999
103. O'neill M.J., Bleakman D., Zimmerman D.M., and Nisenbaum E.S. AMPA receptor potentiators for the treatment of CNS disorders. Curr. Drug Targets CNS Neurol. Disord. 3 (2004) 181-194
104. Ott A., Stolk R.P., Hofman A., van Harskamp F., Grobbee D.E., and Breteler M.M.B. Association of diabetes mellitus and dementia: The Rotterdam study. Diabetologia 39 (1996) 1392-1397
105. Ott A., Stolk R.P., van Harskamp F., Pols H.A.P., Hofman A., and Breteler M.M.B. Diabetes mellitus and the risk of dementia-The Rotterdam Study. Neurology 53 (1999) 1937-1942
106. Passafaro M., Piech V., and Sheng M. Subunit-specific temporal and spatial patterns of AMP A receptor exocytosis in hippocampal neurons. Nat. Neurosci. 4 (2001) 917-926
107. Perez-Villamil B., de la Rosa E.J., Morales A.V., and de Pablo F. Developmentally regulated expression of the preproinsulin gene in the chicken embryo during gastrulation and neurulation. Endocrinology 135 (1994) 2342-2350
108. Pervin S., Singh R., Freije W.A., and Chaudhuri G. MKP-1-induced dephosphorylation of extracellular signal-regulated kinase is essential for triggering nitric oxide-induced apoptosis in human breast cancer cell lines: implications in breast cancer. Cancer Res. 63 (2003) 8853-8860
109. Philpott K.L., McCarthy M.J., Klippel A., and Rubin L.L. Activated phosphatidylinositol 3-kinase and Akt kinase promote survival of superior cervical neurons. J. Cell. Biol. 139 (1997) 809-815
110. Pirart J. Diabetes mellitus and its degenerative complications-prospective-study of 4400 patients observed between 1947 and 1973. Diab. Metab. 3 (1977) 245-256
111. Plas D.R., and Thompson C.B. Akt activation promotes degradation of tuberin and FoxO3a via the proteasome. J. Biol. Chem. 278 (2003) 12361-12366
112. Plum L., Schubert M., and Bruning J.C. The role of insulin receptor signaling in the brain. Trends Endocrinol. Metab. 16 (2005) 59-65
113. Qiu W.Q., and Folstein M.F. Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis. Neurobiol. Aging 27 (2006) 190-198
114. Qiu W.Q., Walsh D.M., Ye Z., Vekrellis K., Zhang J., Podlisny M.B., Rosner M.R., Safavi A., Hersh L.B., and Selkoe D.J. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J. Biol. Chem. 273 (1998) 32730-32738
115. Rodgers E.E., and Theibert A.B. Functions of PI 3-kinase in development of the nervous system. Int. J. Dev. Neurosci. 20 (2002) 187-197
116. Rommel C., Clarke B.A., Zimmermann S., Nunez L., Rossman R., Reid K., Moelling K., Yancopoulos G.D., and Glass D.J. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286 (1999) 1738-1741
117. Rong R., Ahn J.Y., Huang H., Nagata E., Kalman D., Kapp J.A., Tu J., Worley P.F., Snyder S.H., and Ye K. PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis. Nat. Neurosci. 6 (2003) 1153-1161
118. Ryu B.R., Ko H.W., Jou I., Noh J.S., and Gwag B.J. Phosphatidylinositol 3-kinase-mediated regulation of neuronal apoptosis and necrosis by insulin and IGF-I. J. Neurobiol. 39 (1999) 536-546
119. Safavi A., Miller B.C., Cottam L., and Hersh L.B. Identification of gamma-endorphin-generating enzyme as insulin-degrading enzyme. Biochemistry 35 (1996) 14318-14325
120. Sanna P.P., Cammalleri M., Berton F., Simpson C., Lutjens R., Bloom F.E., and Francesconi W. Phosphatidylinositol 3-kinase is required for the expression but not for the induction or the maintenance of long-term potentiation in the hippocampal CA1 region. J. Neurosci. 22 (2002) 3359-3365
121. Schafer M., and Erdo S.L. Insulin-specific sensitization of cultured cerebrocortical neurons to glutamate excitotoxicity. Brain Res. 580 (1992) 331-333
122. Schechter R., Whitmire J., Wheet G.S., Beju D., Jackson K.W., Harlow R., and Gavin III J.R. Immunohistochemical and in situ hybridization study of an insulin-like substance in fetal neuron cell cultures. Brain Res. 636 (1994) 9-27
123. Scheid M.P., and Woodgett J.R. Unravelling the activation mechanisms of protein kinase B/Akt. FEBS Lett. 546 (2003) 108-112
124. Schubert M., Gautam D., Surjo D., Ueki K., Baudler S., Schubert D., Kondo T., Alber J., Galldiks N., Kustermann E., Arndt S., Jacobs A.H., Krone W., Kahn C.R., and Bruning J.C. Role for neuronal insulin resistance in neurodegenerative diseases. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 3100-3105
125. Schwartz M.W., Figlewicz D.P., Baskin D.G., Woods S.C., and Porte Jr. D. Insulin in the brain: a hormonal regulator of energy balance. Endocr. Rev. 13 (1992) 387-414
126. Serrano J., Bevins C.L., Young S.W., and de Pablo F. Insulin gene expression in chicken ontogeny: pancreatic, extrapancreatic, and prepancreatic. Dev. Biol. 132 (1989) 410-418
127. Serrano P., Yao Y., and Sacktor T.C. Persistent phosphorylation by protein kinase Mzeta maintains late-phase long-term potentiation. J. Neurosci. 25 (2005) 1979-1984
128. Shanley L.J., Irving A.J., and Harvey J. Leptin enhances NMDA receptor function and modulates hippocampal synaptic plasticity. J. Neurosci. 21 (2001) RC186
129. Sheng M. The postsynaptic NMDA-receptor-PSD-95 signaling complex in excitatory synapses of the brain. J. Cell. Sci. 114 (2001) 1251
130. Shiiki T., Ohtsuki S., Kurihara A., Naganuma H., Nishimura K., Tachikawa M., Hosoya K., and Terasaki T. Brain insulin impairs amyloid-beta(1-40) clearance from the brain. J. Neurosci. 24 (2004) 9632-9637
131. Shin B.C., Suzuki M., Inukai K., Anai M., Asano T., and Takata K. Multiple isoforms of the regulatory subunit for phosphatidylinositol 3-kinase (PI3-kinase) are expressed in neurons in the rat brain. Biochem. Biophys. Res. Commun. 246 (1998) 313-319
132. Song J., Wu L., Chen Z., Kohanski R.A., and Pick L. Axons guided by insulin receptor in Drosophila visual system. Science 300 (2003) 502-505
133. Stanton P.K. LTD, LTP, and the sliding threshold for long-term synaptic plasticity. Hippocampus 6 (1996) 35-42
134. Steen E., Terry B.M., Rivera E.J., Cannon J.L., Neely T.R., Tavares R., Xu X.J., Wands J.R., and de la Monte S.M. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes?. J. Alzheimer's Dis. 7 (2005) 63-80
135. Stolk R.P., Breteler M.M., Ott A., Pols H.A., Lamberts S.W., Grobbee D.E., and Hofman A. Insulin and cognitive function in an elderly population. The Rotterdam Study. Diab. Care 20 (1997) 792-795
136. Stolk R.P., Pols H.A., Lamberts S.W., de Jong P.T., Hofman A., and Grobbee D.E. Diabetes mellitus, impaired glucose tolerance, and hyperinsulinemia in an elderly population. The Rotterdam Study. Am. J. Epidemiol. 145 (1997) 24-32
137. Storz P., and Toker A. 3′-Phosphoinositide-dependent kinase-1 (PDK-1) in PI 3-kinase signaling. Front. Biosci. 7 (2002) d886-d902
138. Strachan M.W. Insulin and cognitive function in humans: experimental data and therapeutic considerations. Biochem. Soc. Trans. 33 (2005) 1037-1040
139. Subramaniam S., Shahani N., Strelau J., Laliberte C., Brandt R., Kaplan D., and Unsicker K. Insulin-like growth factor 1 inhibits extracellular signal-regulated kinase to promote neuronal survival via the phosphatidylinositol 3-kinase/protein kinase A/c-Raf pathway. J. Neurosci. 25 (2005) 2838-2852
140. Sugimoto K., Murakawa Y., Zhang W., Xu G., and Sima A.A. Insulin receptor in rat peripheral nerve: its localization and alternatively spliced isoforms. Diab. Metab. Res. Rev. 16 (2000) 354-363
141. Sweatt J.D. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J. Neurochem. 76 (2001) 1-10
142. Sweatt J.D. Mitogen-activated protein kinases in synaptic plasticity and memory. Curr. Opin. Neurobiol. 14 (2004) 311-317
143. Taha C., and Klip A. The insulin signaling pathway. J. Membr. Biol. 169 (1999) 1-12
144. Tanaka M., Sawada M., Yoshida S., Hanaoka F., and Marunouchi T. Insulin prevents apoptosis of external granular layer neurons in rat cerebellar slice cultures. Neurosci. Lett. 199 (1995) 37-40
145. Tissenbaum H.A., and Ruvkun G. An insulin-like signaling pathway affects both longevity and reproduction in Caenorhabditis elegans. Genetics 148 (1998) 703-717
146. Toker A. Protein kinases as mediators of phosphoinositide 3-kinase signaling. Mol. Pharmacol. 57 (2000) 652-658
147. Trejo J.L., and Pons S. Phosphatidylinositol-3-OH kinase regulatory subunits are differentially expressed during development of the rat cerebellum. J. Neurobiol. 47 (2001) 39-50
148. Tsai W.C., Bhattacharyya N., Han L.Y., Hanover J.A., and Rechler M.M. Insulin inhibition of transcription stimulated by the forkhead protein Foxol is not solely due to nuclear exclusion. Endocrinology 144 (2003) 5615-5622
149. Unger J.W., and Betz M. Insulin receptors and signal transduction proteins in the hypothalamo-hypophyseal system: a review on morphological findings and functional implications. Histol. Histopathol. 13 (1998) 1215-1224
150. van Dam E.J., Kamal A., Artola A., de Graan P.N., Gispen W.H., and Ramakers G.M. Group I metabotropic glutamate receptors regulate the frequency-response function of hippocampal CA1 synapses for the induction of LTP and LTD. Eur. J. Neurosci. 19 (2004) 112-118
151. van der Heide L.P., Hoekman M.F., Biessels G.J., and Gispen W.H. Insulin inhibits extracellular regulated kinase 1/2 phosphorylation in a phosphatidylinositol 3-kinase (PI3) kinase-dependent manner in Neuro2a cells. J. Neurochem. 86 (2003) 86-91
152. van der Heide L.P., Hoekman M.F., and Smidt M.P. The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem. J. 380 (2004) 291-309
153. van der Heide L.P., Jacobs F.M., Burbach J.P., Hoekman M.F., and Smidt M.P. FoxO6 transcriptional activity is regulated by Thr26 and Serl84, independent of nucleo-cytoplasmic shuttling. Biochem. J. 391 (2005) 623-629
154. van der Heide L.P., Kamal A., Artola A., Gispen W.H., and Ramakers G.M. Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-d-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner. J. Neurochem. 94 (2005) 1158-1166
155. Vanhaesebroeck B., and Alessi D.R. The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346 Pt 3 (2000) 561-576
156. Vanhaesebroeck B., and Waterfield M.D. Signaling by distinct classes of phosphoinositide 3-kinases. Exp. Cell. Res. 253 (1999) 239-254
157. Wan Q., Xiong Z.G., Man H.Y., Ackerley C.A., Braunton J., Lu W.Y., Becker L.E., MacDonald J.F., and Wang Y.T. Recruitment of functional GABA(A) receptors to postsynaptic domains by insulin. Nature 388 (1997) 686-690
158. Wang C., Li Y., Wible B., Angelides K.J., and Ishii D.N. Effects of insulin and insulin-like growth factors on neurofilament mRNA and tubulin mRNA content in human neuroblastoma SH-SY5Y cells. Brain Res. Mol. Brain Res. 13 (1992) 289-300
159. Wang Y.T., and Salter M.W. Regulation of NMDA receptors by tyrosine kinases and phosphatases. Nature 369 (1994) 233-235
160. White M.F. The insulin signalling system and the IRS proteins. Diabetologia 40 Suppl. 2 (1997) S2-S17
161. White M.F. The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol. Cell. Biochem. 182 (1998) 3-11
162. White M.F. IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab. 283 (2002) E413-E422
163. Wiltshire S., Hattersley A.T., Hitman G.A., Walker M., Levy J.C., Sampson M., O'Rahilly S., Frayling T.M., Bell J.I., Lathrop G.M., Bennett A., Dhillon R., Fletcher C., Groves C.J., Jones E., Prestwich P., Simecek N., Rao P.V., Wishart M., Bottazzo G.F., Foxon R., Howell S., Smedley D., Cardon L.R., Menzel S., and McCarthy M.I. A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome lq. Am. J. Hum. Genet. 69 (2001) 553-569
164. Woods S.C., Seeley R.J., Baskin D.G., and Schwartz M.W. Insulin and the blood-brain barrier. Curr. Pharm. Des. 9 (2003) 795-800
165. Wozniak M., Rydzewski B., Baker S.P., and Raizada M.K. The cellular and physiological actions of insulin in the central nervous system. Neurochem. Int. 22 (1993) 1-10
166. Wu X., Zhu D., Jiang X., Okagaki P., Mearow K., Zhu G., McCall S., Banaudha K., Lipsky R.H., and Marini A.M. AMPA protects cultured neurons against glutamate excitotoxicity through a phosphatidylinositol 3-kinase-dependent activation in extracellular signal-regulated kinase to upregulate BDNF gene expression. J. Neurochem. 90 (2004) 807-818
167. Yamada K., and Nabeshima T. Brain-derived neurotrophic factor/TrkB signaling in memory processes. J. Pharmacol. Sci. 91 (2003) 267-270
168. Yamaguchi A., Tamatani M., Matsuzaki H., Namikawa K., Kiyama H., Vitek M.P., Mitsuda N., and Tohyama M. Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53. J. Biol. Chem. 276 (2001) 5256-5264
169. Zhao L., Teter B., Morihara T., Lim G.P., Ambegaokar S.S., Ubeda O.J., Frautschy S.A., and Cole G.M. Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention. J. Neurosci. 24 (2004) 11120-11126
170. Zhao W., Chen H., Xu H., Moore E., Meiri N., Quon M.J., and Alkon D.L. Brain insulin receptors and spatial memory. correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. J. Biol. Chem. 274 (1999) 34893-34902
171. Zheng W.H., Kar S., and Quirion R. Insulin-like growth factor-1-induced phosphorylation of transcription factor FKHRL1 is mediated by phosphatidylinositol 3-kinase/Akt kinase and role of this pathway in insulin-like growth factor-1-induced survival of cultured hippocampal neurons. Mol. Pharmacol. 62 (2002) 225-233
172. Zhu D., Lipsky R.H., and Marini A.M. Co-activation of the phosphatidylinositol-3-kinase/Akt signaling pathway by N-methyl-d-aspartate and TrkB receptors in cerebellar granule cell neurons. Amino Acids 23 (2002) 11-17
173. Zimmermann S., and Moelling K. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286 (1999) 1741-1744